Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: capecitabine|DRUG: docetaxel|DRUG: epirubicin hydrochloride|OTHER: laboratory biomarker analysis|OTHER: pharmacogenomic studies|PROCEDURE: biopsy|PROCEDURE: neoadjuvant therapy|PROCEDURE: therapeutic surgical procedure
Sponsor: Mayo Clinic
Collaborators: National Cancer Institute (NCI)